ask="4.78"
ask_size="600"
average_daily_volume="1554270"
bid="4.52"
bid_size="100"
book_value="0.21"
change="-0.21"
change_from_200_day_moving_average="-0.83"
change_from_50_day_moving_average="-1.27"
change_from_52_week_high="-3.21"
change_From_52_week_low="1.48"
change_in_percent="-4.38%"
close="4.59"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.45"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.61"
ex_dividend_date="N/A"
float_shares="71244000"
high="4.81"
high_52_weeks="7.80"
last_trade_date="1/30/2017"
last_trade_price="4.59"
last_trade_size="46213"
last_trade_time="4:00pm"
low="4.54"
low_52_weeks="3.11"
market_capitalization="486.36M"
moving_average_200_day="5.42"
moving_average_50_day="5.86"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="4.77"
pe_ratio="N/A"
peg_ratio="-0.03"
percent_change_from_200_day_moving_average="-15.37%"
percent_change_from_50_day_moving_average="-21.67%"
percent_change_from_52_week_high="-41.15%"
percent_change_from_52_week_low="+47.59%"
previous_close="4.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="23.08"
price_per_sales="18.01"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="16.17"
stock_exchange="NCM"
symbol="KERX"
volume="1212364"
weeks_range_52="3.11 - 7.80"
